DF
GILD icon

Dunhill Financial’s Gilead Sciences GILD Stock Holding History

Dunhill Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$32 – 1956
2025
Q4 		$32 Buy
+6
New +$729 ﹤0.01% 1798

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dunhill Financial's GILD Position: Q2 2026 in Review

Dunhill Financial reduced its Gilead Sciences (GILD) stake by 0.7% in Q2 2026, selling an estimated $395 and leaving 424 shares worth $53.7K. The position accounts for 0.01% of the portfolio, ranked #316.

Dunhill Financial first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $125K in Q4 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dunhill Financial held 424 shares of Gilead Sciences worth $53.7K as of Q2 2026.
  • Dunhill Financial sold 3 Gilead Sciences shares in Q2 2026, an estimated $395.
  • Gilead Sciences made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #316 holding.
  • Dunhill Financial first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Gilead Sciences position peaked at $125K in Q4 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.